Research graph
References from Analytical validation of a multiplexed peptide microarray for multi-antigen Epstein–Barr virus serological profiling across diverse clinical specimens. Local targets link to admitted publications; unresolved targets remain external evidence.
Epstein-Barr virus: Biology and clinical disease
10.1016/j.cell.2022.08.026 · 2022 · External reference
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
10.1126/science.abj8222 · 2022 · External reference
Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications
10.1038/s41582-023-00775-5 · 2023 · External reference
Epstein barr virus and autoimmune responses in systemic lupus erythematosus
10.3389/fimmu.2020.623944 · 2020 · External reference
Estimating the global burden of Epstein-Barr virus-related cancers
10.1007/s00432-021-03824-y · 2022 · External reference
Evidence-based approach for interpretation of Epstein-Barr virus serological patterns
10.1128/jcm.00164-09 · 2009 · External reference
Unresolved reference
External reference
A peptide microarray platform approach for discovery of immunodominant antibody epitopes
10.1021/acs.analchem.4c02806 · 2024 · External reference
On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions
10.1038/nm.2913 · 2012 · External reference
High-density peptide microarray analysis of IgG autoantibody reactivities in serum and cerebrospinal fluid of multiple sclerosis patients
10.1074/mcp.m115.051664 · 2016 · External reference
Immunosignaturing: a critical review
10.1016/j.tibtech.2012.10.012 · 2013 · External reference
General assessment of humoral activity in healthy humans
10.1074/mcp.m115.054601 · 2016 · External reference
A simple platform for the rapid development of antimicrobials
10.1038/s41598-017-17941-7 · 2017 · External reference
Non-natural amino acid peptide microarrays to discover Ebola virus glycoprotein ligands
10.1039/c7cc08242h · 2018 · External reference
Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics
10.1586/14789450.3.4.409 · 2006 · External reference
Impact of blood collection devices on clinical chemistry assays
10.1016/j.clinbiochem.2009.10.001 · 2010 · External reference
Guidelines for the preanalytical conditions for analyzing circulating cell-free DNA
10.1373/clinchem.2018.298323 · 2019 · External reference
Performance of streck cfDNA blood collection tubes for liquid biopsy testing
10.1371/journal.pone.0166354 · 2016 · External reference
Comparative analysis of circulating tumor DNA stability In K
10.1016/j.clinbiochem.2016.03.012 · 2016 · External reference
Liquid biopsies come of age: towards implementation of circulating tumour DNA
10.1038/nrc.2017.7 · 2017 · External reference
Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray
10.1371/journal.pone.0179124 · 2017 · External reference
Serologic response to the epstein-barr virus peptidome and the risk for multiple sclerosis
10.1001/jamaneurol.2024.0272 · 2024 · External reference
In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis
10.3389/fimmu.2024.1487523 · 2024 · External reference
Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development
10.1002/eji.202049101 · 2021 · External reference
Unresolved reference
2024 · External reference
Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening
10.1128/jcm.44.4.1459-1467.2006 · 2006 · External reference
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
10.1038/s41586-022-04432-7 · 2022 · External reference
Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls
10.1073/pnas.2424986122 · 2025 · External reference
Accumulation of Epstein-Barr virus-induced cross-reactive immune responses is associated with multiple sclerosis
10.1172/jci184481 · 2024 · External reference
